Introduction to Afzanna Tablets
Afzanna Tablets contain afatinib dimaleate, a targeted anticancer medicine prescribed for certain adults with non-small cell lung cancer (NSCLC). It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which act on specific proteins involved in cancer-cell growth.
Cordium Pharmaceuticals Pvt. Ltd. provides pharmaceutical product information and supports enquiries from eligible healthcare and pharmaceutical buyers. This page explains the available Afzanna tablet strengths, their medical use and important considerations for safe handling and procurement in India.
Afzanna Tablets Strengths Available in India
Afzanna Tablets are listed in the following strengths:
Afzanna 20mg Tablets
Afzanna 30mg Tablets
Afzanna 40mg Tablets
These strengths contain afatinib dimaleate and may be prescribed according to the patient's clinical condition, treatment response and tolerance.
Actual product availability, packaging and manufacturer details should be confirmed before placing a procurement enquiry. Buyers should verify the product label and approved documentation for the specific batch.
What Are Afzanna Tablets Used For?
Afzanna Tablets are used to treat certain types of non-small cell lung cancer, particularly cases associated with specific epidermal growth factor receptor (EGFR) mutations.
Afatinib works by blocking signalling through members of the ErbB receptor family, including EGFR. These signalling pathways can contribute to cancer-cell growth and multiplication. By inhibiting them, afatinib can help control the progression of selected cancers.
Treatment suitability depends on the cancer diagnosis, relevant molecular testing and the treating oncologist's assessment. Afzanna is a prescription medicine and should not be used without appropriate medical supervision.
How Is the Appropriate Strength Determined?
The treating oncologist determines the appropriate strength and treatment schedule. Factors may include the patient's diagnosis, overall health, response to therapy and adverse reactions.
Patients should follow their prescription and the product leaflet carefully. They must not increase, reduce or discontinue the dose without consulting their healthcare professional.
Important Safety Information and Possible Side Effects
Afatinib may cause side effects that require monitoring. Commonly reported reactions include:
Diarrhoea
Skin rash and acne-like eruptions
Dry skin and itching
Mouth inflammation
Nausea or vomiting
Reduced appetite and nail problems
Some reactions can become serious. Persistent diarrhoea, breathing difficulties, severe skin reactions, eye problems or signs of liver complications require prompt medical assessment.
Patients should inform their doctor about existing medical conditions, pregnancy or breastfeeding, and all medicines or supplements they use. Regular monitoring may be necessary throughout treatment.
Pharmaceutical Product Enquiries with Cordium Pharmaceuticals Pvt. Ltd.
Cordium Pharmaceuticals Pvt. Ltd. welcomes enquiries from eligible pharmaceutical distributors, hospitals and authorised healthcare procurement organisations seeking product information.
For Afzanna Tablets, buyers should specify the required strength—20mg, 30mg or 40mg—along with the requested quantity and destination. Product availability, manufacturer information, packaging, storage requirements and applicable regulatory documentation should be verified before an order is confirmed.
Any supply or distribution must comply with applicable Indian pharmaceutical regulations and the requirements of the destination market.
Frequently Asked Questions About Afzanna Tablets
What are the strengths of Afzanna Tablets?
Afzanna Tablets are listed in 20mg, 30mg and 40mg strengths. Confirm the exact product details before procurement.
What is the main use of Afzanna Tablets?
They are prescribed for certain forms of non-small cell lung cancer, depending on the patient's cancer characteristics and clinical assessment.
Can Afzanna Tablets be taken without a prescription?
No. Afzanna is a prescription anticancer medicine and requires supervision by a qualified healthcare professional.
How can pharmaceutical buyers enquire about Afzanna Tablets?
Eligible buyers can contact Cordium Pharmaceuticals Pvt. Ltd. with their required strength, quantity and destination to enquire about product information and availability.
Conclusion
Afzanna Tablets contain afatinib dimaleate and are used in selected cases of non-small cell lung cancer. Understanding the available strengths, treatment indications and safety considerations is important for patients and pharmaceutical buyers.
Cordium Pharmaceuticals Pvt. Ltd. encourages buyers to verify product specifications and regulatory documentation before procurement and to consult qualified healthcare professionals for all treatment-related decisions.
Afzanna Tablets contain afatinib dimaleate, a targeted anticancer medicine prescribed for certain adults with non-small cell lung cancer (NSCLC). It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which act on specific proteins involved in cancer-cell growth.
Cordium Pharmaceuticals Pvt. Ltd. provides pharmaceutical product information and supports enquiries from eligible healthcare and pharmaceutical buyers. This page explains the available Afzanna tablet strengths, their medical use and important considerations for safe handling and procurement in India.
Afzanna Tablets Strengths Available in India
Afzanna Tablets are listed in the following strengths:
Afzanna 20mg Tablets
Afzanna 30mg Tablets
Afzanna 40mg Tablets
These strengths contain afatinib dimaleate and may be prescribed according to the patient's clinical condition, treatment response and tolerance.
Actual product availability, packaging and manufacturer details should be confirmed before placing a procurement enquiry. Buyers should verify the product label and approved documentation for the specific batch.
What Are Afzanna Tablets Used For?
Afzanna Tablets are used to treat certain types of non-small cell lung cancer, particularly cases associated with specific epidermal growth factor receptor (EGFR) mutations.
Afatinib works by blocking signalling through members of the ErbB receptor family, including EGFR. These signalling pathways can contribute to cancer-cell growth and multiplication. By inhibiting them, afatinib can help control the progression of selected cancers.
Treatment suitability depends on the cancer diagnosis, relevant molecular testing and the treating oncologist's assessment. Afzanna is a prescription medicine and should not be used without appropriate medical supervision.
How Is the Appropriate Strength Determined?
The treating oncologist determines the appropriate strength and treatment schedule. Factors may include the patient's diagnosis, overall health, response to therapy and adverse reactions.
Patients should follow their prescription and the product leaflet carefully. They must not increase, reduce or discontinue the dose without consulting their healthcare professional.
Important Safety Information and Possible Side Effects
Afatinib may cause side effects that require monitoring. Commonly reported reactions include:
Diarrhoea
Skin rash and acne-like eruptions
Dry skin and itching
Mouth inflammation
Nausea or vomiting
Reduced appetite and nail problems
Some reactions can become serious. Persistent diarrhoea, breathing difficulties, severe skin reactions, eye problems or signs of liver complications require prompt medical assessment.
Patients should inform their doctor about existing medical conditions, pregnancy or breastfeeding, and all medicines or supplements they use. Regular monitoring may be necessary throughout treatment.
Pharmaceutical Product Enquiries with Cordium Pharmaceuticals Pvt. Ltd.
Cordium Pharmaceuticals Pvt. Ltd. welcomes enquiries from eligible pharmaceutical distributors, hospitals and authorised healthcare procurement organisations seeking product information.
For Afzanna Tablets, buyers should specify the required strength—20mg, 30mg or 40mg—along with the requested quantity and destination. Product availability, manufacturer information, packaging, storage requirements and applicable regulatory documentation should be verified before an order is confirmed.
Any supply or distribution must comply with applicable Indian pharmaceutical regulations and the requirements of the destination market.
Frequently Asked Questions About Afzanna Tablets
What are the strengths of Afzanna Tablets?
Afzanna Tablets are listed in 20mg, 30mg and 40mg strengths. Confirm the exact product details before procurement.
What is the main use of Afzanna Tablets?
They are prescribed for certain forms of non-small cell lung cancer, depending on the patient's cancer characteristics and clinical assessment.
Can Afzanna Tablets be taken without a prescription?
No. Afzanna is a prescription anticancer medicine and requires supervision by a qualified healthcare professional.
How can pharmaceutical buyers enquire about Afzanna Tablets?
Eligible buyers can contact Cordium Pharmaceuticals Pvt. Ltd. with their required strength, quantity and destination to enquire about product information and availability.
Conclusion
Afzanna Tablets contain afatinib dimaleate and are used in selected cases of non-small cell lung cancer. Understanding the available strengths, treatment indications and safety considerations is important for patients and pharmaceutical buyers.
Cordium Pharmaceuticals Pvt. Ltd. encourages buyers to verify product specifications and regulatory documentation before procurement and to consult qualified healthcare professionals for all treatment-related decisions.
Keywords
